[go: up one dir, main page]

NO984370L - Propofol-smÕdrÕpeformuleringer - Google Patents

Propofol-smÕdrÕpeformuleringer

Info

Publication number
NO984370L
NO984370L NO984370A NO984370A NO984370L NO 984370 L NO984370 L NO 984370L NO 984370 A NO984370 A NO 984370A NO 984370 A NO984370 A NO 984370A NO 984370 L NO984370 L NO 984370L
Authority
NO
Norway
Prior art keywords
propofol
pml
devoid
surrounded
volume
Prior art date
Application number
NO984370A
Other languages
English (en)
Other versions
NO324498B1 (no
NO984370D0 (no
Inventor
Duncan H Haynes
Original Assignee
Res Triangle Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24469788&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO984370(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Res Triangle Pharm Ltd filed Critical Res Triangle Pharm Ltd
Publication of NO984370D0 publication Critical patent/NO984370D0/no
Publication of NO984370L publication Critical patent/NO984370L/no
Publication of NO324498B1 publication Critical patent/NO324498B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO19984370A 1996-03-19 1998-09-18 Mikro-smadrape og steril injiserbar farmasoytisk blanding NO324498B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/616,511 US5637625A (en) 1996-03-19 1996-03-19 Propofol microdroplet formulations
PCT/US1997/004168 WO1997034588A1 (en) 1996-03-19 1997-03-17 Propofol microdroplet formulations

Publications (3)

Publication Number Publication Date
NO984370D0 NO984370D0 (no) 1998-09-18
NO984370L true NO984370L (no) 1998-09-18
NO324498B1 NO324498B1 (no) 2007-10-29

Family

ID=24469788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984370A NO324498B1 (no) 1996-03-19 1998-09-18 Mikro-smadrape og steril injiserbar farmasoytisk blanding

Country Status (19)

Country Link
US (1) US5637625A (no)
EP (1) EP0796616B1 (no)
JP (1) JP2000507244A (no)
KR (1) KR100484516B1 (no)
CN (1) CN1124845C (no)
AT (1) ATE182074T1 (no)
AU (1) AU719756B2 (no)
BR (1) BR9708099B8 (no)
CA (1) CA2249375C (no)
DE (1) DE69700317T2 (no)
DK (1) DK0796616T3 (no)
ES (1) ES2135969T3 (no)
FI (1) FI982009L (no)
GR (1) GR3031414T3 (no)
HU (1) HU225046B1 (no)
NO (1) NO324498B1 (no)
NZ (1) NZ331669A (no)
RU (1) RU2186564C2 (no)
WO (1) WO1997034588A1 (no)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070117862A1 (en) * 1993-02-22 2007-05-24 Desai Neil P Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
KR100508910B1 (ko) 1995-10-17 2006-04-20 알티피 파마 코포레이션 불용성약물방출
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) * 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
CH692322A5 (it) * 1997-05-26 2002-05-15 Westy Ag Formulazione iniettabile limpida di Propofol.
EP1023050B1 (en) * 1997-06-27 2013-09-25 Abraxis BioScience, LLC Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
ES2292233T3 (es) * 1998-02-10 2008-03-01 Sicor Inc. Composicion de propofol que contiene sulfito.
IL137734A0 (en) * 1998-02-11 2001-10-31 Res Triangle Pharm Ltd Method and composition for treatment of inflammatory conditions
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
US6254853B1 (en) * 1998-05-08 2001-07-03 Vyrex Corporation Water soluble pro-drugs of propofol
ES2216517T3 (es) 1998-05-29 2004-10-16 Skyepharma Canada Inc. Composiciones de microcapsulas termoprotegidas y procedimiento para su esterilizacion terminal con vapor.
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
AU759641B2 (en) * 1998-08-19 2003-04-17 Skyepharma Canada Inc. Injectable aqueous dispersions of propofol
US6150423A (en) 1998-10-15 2000-11-21 Phoenix Scientific, Inc. Propofol-based anesthetic and method of making same
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
BR9915738A (pt) 1998-11-20 2001-10-02 Rtp Pharma Inc Micropartìculas estabilizadas em fosfolipìdeos dispersìveis
ES2232195T3 (es) * 1999-01-28 2005-05-16 Dinesh Shantilal Patel Solucion parenteral de propofol (2,6-diisopropilfenol) y 2,5-di-o-metil-1,4;3,6-dianhidro-d-glucitol como solvente.
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6100302A (en) * 1999-04-05 2000-08-08 Baxter International Inc. Propofol formulation with enhanced microbial characteristics
GB2350297A (en) * 1999-05-27 2000-11-29 Abbott Lab Injectable halogenated anesthetic formulation in emulsion form
IL148685A0 (en) * 1999-09-21 2002-09-12 Rtp Pharma Inc Surface modified particulate compositions of biologically active substances
US6071933A (en) * 1999-12-03 2000-06-06 Diversified Medical Innovations, Inc. Homogeneous remifentanil-propofol blend for patient controlled anesthesia and process for its use
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
EP1276465B1 (en) 2000-04-20 2014-03-12 Jagotec AG Improved water-insoluble drug particle process
IL153457A0 (en) 2000-06-16 2003-07-06 Skyepharma Canada Inc Improved injectable dispersions of propofol
US6623765B1 (en) 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
ATE424811T1 (de) 2000-08-31 2009-03-15 Jagotec Ag Gemahlene partikel
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
ATE522211T1 (de) * 2000-09-20 2011-09-15 Jagotec Ag Stabilisierte fibrat-mikropartikel
WO2002067901A1 (en) * 2001-02-22 2002-09-06 Skyepharma Canada Inc. Fibrate-statin combinations with reduced fed-fasted effects
US6991809B2 (en) 2001-06-23 2006-01-31 Lyotropic Therapeutics, Inc. Particles with improved solubilization capacity
US20030054042A1 (en) * 2001-09-14 2003-03-20 Elaine Liversidge Stabilization of chemical compounds using nanoparticulate formulations
CN1558755A (zh) * 2001-09-26 2004-12-29 ���ع��ʹ�˾ 通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
EP1430017A2 (en) 2001-09-26 2004-06-23 Theravance, Inc. Substituted phenol compounds useful for anesthesia and sedation
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
ES2325918T3 (es) * 2001-12-28 2009-09-24 Eisai Corporation Of North America Formulaciones farmaceuticas de base acuosa de profarmacos de propofol solubles en agua.
US20080220075A1 (en) * 2002-03-20 2008-09-11 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
EP1490030B2 (en) * 2002-03-20 2010-07-14 Elan Pharma International Limited Nanoparticulate compositions of angiogenesis inhibitors
JP5188003B2 (ja) * 2002-04-08 2013-04-24 エーザイ インコーポレイテッド プロポフォールの水溶性プロドラッグを含む薬学的組成物およびその投与方法
US7550155B2 (en) * 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
US20040220283A1 (en) * 2002-07-29 2004-11-04 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
RS54275B1 (sr) * 2002-07-29 2016-02-29 Transform Pharmaceuticals, Inc. Vodeni 2,6-diizopropilfenol farmaceutski sastavi
AU2003286725B2 (en) * 2002-10-29 2007-07-12 Transform Pharmaceuticals, Inc. Propofol with cysteine
RU2335279C2 (ru) * 2002-12-06 2008-10-10 Оцука Фармасьютикал Фэктори, Инк. Жировые эмульсии, содержащие пропофол
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) * 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US7182948B2 (en) * 2003-08-04 2007-02-27 Ko Manufacturing, Inc. Topical veterinary compositions and methods for the treatment and prevention of infection
EP1706148A2 (en) * 2004-01-14 2006-10-04 Gilead Sciences, Inc. Lipid-based dispersions useful for drug delivery
US7125954B2 (en) 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
MX2007015183A (es) * 2005-06-14 2008-02-19 Baxter Int Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco.
CA2620389C (en) * 2005-08-31 2014-06-17 Abraxis Bioscience, Llc Compositions and methods for preparation of poorly water soluble drugs with increased stability
PT1931321T (pt) * 2005-08-31 2019-05-14 Abraxis Bioscience Llc Composições compreendendo agentes farmacêuticos pouco hidrossolúveis e agentes antimicrobianos
EP1954245A2 (en) * 2005-11-15 2008-08-13 Baxter International Inc. Compositions of lipoxygenase inhibitors
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
RU2535001C1 (ru) * 2013-07-11 2014-12-10 Общество с ограниченной ответственностью "ВИК-здоровье животных" Микроколлоидный раствор пропофола для анестезии
US20160346221A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
WO2016196648A1 (en) * 2015-06-01 2016-12-08 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
WO2017218630A2 (en) * 2016-06-15 2017-12-21 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
CN114867467B (zh) * 2019-12-20 2025-06-20 费森尤斯卡比奥地利有限公司 用于产生水包油乳剂的方法
EP4056038A1 (en) * 2021-03-10 2022-09-14 Basf Se Microparticles containing active substances

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
US4725442A (en) * 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
CH669523A5 (no) * 1986-06-25 1989-03-31 Mepha Ag
SU1569018A1 (ru) * 1987-07-07 1990-06-07 Ленинградский химико-фармацевтический институт Способ нанесени покрыти на таблетки
DE4132677C2 (de) * 1991-10-01 1995-08-24 Braun Melsungen Ag Flüchtige Inhalationsnarkotika enthaltende Liposomen, ihre Herstellung und Verwendung
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5496537A (en) * 1995-03-23 1996-03-05 Henry; Richard A. Propofol hydrofluorocarbon propellant formulations

Also Published As

Publication number Publication date
CA2249375C (en) 2002-06-18
CN1218398A (zh) 1999-06-02
ATE182074T1 (de) 1999-07-15
NZ331669A (en) 2000-01-28
BR9708099B8 (pt) 2014-04-29
JP2000507244A (ja) 2000-06-13
KR20000064762A (ko) 2000-11-06
RU2186564C2 (ru) 2002-08-10
DE69700317T2 (de) 1999-12-02
US5637625A (en) 1997-06-10
WO1997034588A1 (en) 1997-09-25
FI982009A0 (fi) 1998-09-17
GR3031414T3 (en) 2000-01-31
FI982009A7 (fi) 1998-09-17
EP0796616B1 (en) 1999-07-14
KR100484516B1 (ko) 2005-09-02
HU225046B1 (hu) 2006-05-29
CN1124845C (zh) 2003-10-22
CA2249375A1 (en) 1997-09-25
BR9708099B1 (pt) 2010-02-23
NO324498B1 (no) 2007-10-29
AU719756B2 (en) 2000-05-18
BR9708099A (pt) 2000-01-04
DE69700317D1 (de) 1999-08-19
EP0796616A1 (en) 1997-09-24
DK0796616T3 (da) 1999-11-29
FI982009L (fi) 1998-09-17
NO984370D0 (no) 1998-09-18
AU2329297A (en) 1997-10-10
HUP9902553A3 (en) 2001-04-28
HUP9902553A2 (hu) 2000-10-28
ES2135969T3 (es) 1999-11-01

Similar Documents

Publication Publication Date Title
NO984370L (no) Propofol-smÕdrÕpeformuleringer
CA2207218A1 (en) Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
RU98118914A (ru) Изготовление лекарственных средств из микрокапель пропофола
WO1996028131A3 (de) Kosmetische oder pharmazeutische mikroemulsionen
KR100414853B1 (no)
CA2146757A1 (en) Stabilization of fluorocarbon emulsions
ATE186905T1 (de) Gemisch mit hohem gehalt an cis beta-carotin
CA2139625A1 (en) A microencapsulated oil or fat product
FI954325A0 (fi) Varjoaineisiin liittyviä parannuksia
KR910005760A (ko) 살충제 및/또는 살비제 조성물
MXPA97007996A (es) Preparado para el transporte de sustancias activas a traves de barreras.
MX9500133A (es) Emulsiones de agua/aceite de alta fase interna.
BR9407052A (pt) Misturas de combustiveis
KR970014571A (ko) 1,2-디브로모-2,4-디시아노부탄과 파라하이드록시벤조산 에스테르와의 상승작용성 항미생물성 조성물
CA2169657A1 (fr) Procede de rehabilitation de sols contamines par hydrocarbures et autres substances biodegradables
AU6460399A (en) Method for producing a biological substance, biological substance and the use thereof
KR900001370A (ko) 이부딜라스트 지질 미세구 및 그의 제조방법
KR950702385A (ko) 콜레토트리컴 속균 및 그 용도
CA2220178A1 (en) Dry preparations containing microbially produced oil
WO1999004749A3 (de) Multiple w/o/w-emulsionen mit hohem polyolgehalt
RU94044961A (ru) Способ получения масла из семян амаранта
KR970009793A (ko) 이부프로펜 용액을 함유한 연질캅셀제
EP0739590A3 (en) Triglycerides, rich in polyunsaturated fatty acids
KR970010714A (ko) 유중수형 유제 폭약용 유화제 및 그의 제조 방법
Le Blanc et al. Standard purification and detoxification procedures for bis (F-alkyl) ethenes to be used in medicine and biology. Use of namalva lymphoid cell cultures as a toxicity test

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees